Hypera S.A.
HYPE3
Rank in Stocks
#4245
Based in São Paulo, Brazil, Hypera S.A. is a prominent pharmaceutical... Based in São Paulo, Brazil, Hypera S.A. is a prominent pharmaceutical enterprise. The company's comprehensive product line encompasses a wide array of prescription medications, featuring established brands such as Adacne, Celestamine, Cizax, Diprosone, and Emprol XR, among many others. Beyond prescription drugs, Hypera offers specialized dermo-cosmetics through its Mantecorp Skincare brand. Its consumer health division markets popular remedies like Apracur, Benegrip, Engov, and Estomazil. Additionally, Hypera provides nutritional and vitamin supplements, including well-known names such as Tamarine, Vitasay, Biotônico Fontoura, and Zero-Cal. The company also maintains a significant presence in the generic and similar medicines market, offering products under the Neo Química brand and common formulations like Ibuprofen, Paracetamol, and Omeprazole. The organization officially became Hypera S.A. in February 2018, having previously operated as Hypermarcas S.A.
Share Price
$5.31
Market Cap
$3.74B
Change (1 day)
1.78%
Change (1 year)
24.80%
Country
BR
Trade Hypera S.A. (HYPE3)
Category
Healthcare
Stock split history for Hypera S.A. (HYPE3)
Hypera S.A. stock (symbol: HYPE3) underwent a total of 0 stock splits.
The most recent stock split occurred on Oct 21, 2026.
One HYPE3 share bought prior to Oct 21, 2026 would equal to 0 HYPE3 shares today.
The most recent stock split occurred on Oct 21, 2026.
One HYPE3 share bought prior to Oct 21, 2026 would equal to 0 HYPE3 shares today.
Stock split list
| Year | Split | Multiple | Cumulative Multiple |
|---|---|---|---|
| Not enough data for the provided dates. | |||
Stock splits for similar companies or competitors
| Company | Number of stock splits | Cumulative Multiple | Country |
|---|---|---|---|
| 0 | - |
DE
|
|
| 0 | - |
DE
|
|
| 0 | - |
JP
|
|
| 0 | - |
CH
|
|
| 5 | x119 |
IN
|
